bexarotene has been researched along with prostaglandin d2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreeff, M; Duvic, M; Konopleva, M; Ni, X; Zhang, C | 1 |
Bissonnette, RP; Cesario, RM; Lamph, WW; Stone, J; Yen, WC | 1 |
2 other study(ies) available for bexarotene and prostaglandin d2
Article | Year |
---|---|
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bexarotene; Cell Division; Cell Line, Tumor; Drug Synergism; Humans; Immunologic Factors; Ligands; Lymphocytes; Mycosis Fungoides; Nitric Oxide; Oleanolic Acid; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Transcription Factors | 2004 |
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Fibrinolytic Agents; Humans; Male; Membrane Proteins; Mice; Mice, Nude; PPAR gamma; Prostaglandin D2; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazolidinediones; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |